<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Vinall, Maria</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Topol, Eric J.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">The Genomics of Cardiovascular Disease</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2008</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2008-05-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">4-5</style></pages><abstract><style  face="normal" font="default" size="100%">Single nucleotide polymorphisms (SNP) are useful for comparing regions of the genome between cohorts with and without a particular disease. There are six diseases that have an extensive genomic definition: type 2 diabetes, Crohn's disease, breast cancer, age-related macular degeneration, prostate cancer, and systemic lupus erythematosus. Of particular interest to cardiologists, SNPs have been defined for myocardial infarction, coronary artery disease, atrial fibrillation, lipoprotein disorders, and hypercholesterolemia.</style></abstract><number><style face="normal" font="default" size="100%">2</style></number><volume><style face="normal" font="default" size="100%">8</style></volume></record></records></xml>